This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Aduro Biotech Inc., University of California. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 29 
2 out of 16,025 
Years Active: 2017-2020
Title: Edward Emile Lemmens: Innovator in Immune Stimulators
Introduction
Edward Emile Lemmens is a distinguished inventor based in Walnut Creek, California. He has made significant contributions to the field of immunology, holding a total of four patents focused on the development of cyclic-di-nucleotide immune stimulators. His innovative work aims to enhance immune responses, which can have a profound impact on therapeutic approaches for various diseases.
Latest Patents
Among his latest patents, Lemmens has developed compositions and methods for activating 'stimulator of interferon gene'-dependent signaling. One notable invention provides highly active cyclic-di-nucleotide immune stimulators that activate dendritic cells via a cytoplasmic receptor known as STING (Stimulator of Interferon Genes). These compositions include substantially pure cyclic purine dinucleotides that induce STING-dependent type I interferon production.
Another significant patent from Lemmens includes compositions comprising cyclic purine dinucleotides with defined stereochemistries and methods for their preparation and use. This invention offers novel and highly active cyclic-di-nucleotide immune stimulators that activate dendritic cells through STING, focusing on substantially pure stereoisomers for enhanced efficacy.
Career Highlights
Edward Emile Lemmens has worked with reputable organizations such as Aduro Biotech Inc. and the University of California. His employment in these institutions highlights his dedication to research and innovation, driving advancements in the field of immunotherapy.
Collaborations
Throughout his career, Lemmens has collaborated with distinguished colleagues, including Thomas W. Dubensky, Jr. and David Braun Kanne. These partnerships have likely contributed to the successful development of his patents and innovations in immune stimulation.
Conclusion
Edward Emile Lemmens has emerged as a key inventor in the realm of immune system enhancement through his innovative patents focused on cyclic-di-nucleotide immune stimulators. His ongoing research and contributions continue to pave the way for novel therapies in immunology, demonstrating the importance of collaboration and creativity in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile